{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:51:13Z","timestamp":1791298273689,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.medmal.2015.11.013","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T10:16:20Z","timestamp":1451470580000},"page":"4-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vaccine strategies against bacterial pathogens in cystic fibrosis patients"],"prefix":"10.1016","volume":"46","author":[{"given":"V.","family":"Le Moigne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2015.11.013_bib0320","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.medmal.2015.11.013_bib0325","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4187\/aarc0427","article-title":"Cystic fibrosis: pathogenesis and future treatment strategies","volume":"54","author":"Ratjen","year":"2009","journal-title":"Resp Care"},{"key":"10.1016\/j.medmal.2015.11.013_bib0330","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2015.11.013_bib0335","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/adc.47.256.908","article-title":"Bacterial Infection in cystic fibrosis","volume":"47","author":"May","year":"1972","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.medmal.2015.11.013_bib0340","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990\u20132020","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.medmal.2015.11.013_bib0345","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2015.11.013_bib0350","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.micinf.2003.08.009","article-title":"Antimicrobial resistance of Pseudomonas\u00a0aeruginosa biofilms","volume":"5","author":"Drenkard","year":"2003","journal-title":"Microb Infect"},{"key":"10.1016\/j.medmal.2015.11.013_bib0355","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1099\/ijs.0.023770-0","volume":"61","author":"Leao","year":"2011","journal-title":"IntJ Syst Evol Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0360","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200207-679OC","article-title":"Nontuberculous mycobacteria","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2015.11.013_bib0365","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0370","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/ajrccm.185.2.231","article-title":"Respiratory outbreak of Mycobacterium\u00a0abscessus subspecies massiliense in a lung transplant and cystic fibrosis center","volume":"185","author":"Aitken","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2015.11.013_bib0375","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(13)60632-7","article-title":"Whole-genome sequencing to identify transmission of Mycobacterium\u00a0abscessus between patients with cystic fibrosis: a retrospective cohort study","volume":"381","author":"Bryant","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2015.11.013_bib0380","doi-asserted-by":"crossref","first-page":"e5660","DOI":"10.1371\/journal.pone.0005660","article-title":"Nonmycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium\u00a0abscessus","volume":"4","author":"Ripoll","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.medmal.2015.11.013_bib0385","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium\u00a0abscessus but is absent from Mycobacterium\u00a0chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2015.11.013_bib0390","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1128\/JCM.39.2.816-819.2001","article-title":"Fatal pulmonary infection due to multidrug-resistant Mycobacterium\u00a0abscessus in a patient with cystic fibrosis","volume":"39","author":"Sanguinetti","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0395","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2006.04.003","article-title":"Mycobacterium\u00a0abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient","volume":"25","author":"Taylor","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.medmal.2015.11.013_bib0400","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2012.06.009","article-title":"Mycobacterium\u00a0avium and Mycobacterium\u00a0abscessus complex target distinct cystic fibrosis patient subpopulations","volume":"12","author":"Catherinot","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.medmal.2015.11.013_bib0405","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.medmal.2015.11.013_bib0410","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.vaccine.2015.03.030","article-title":"Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium\u00a0abscessus model","volume":"33","author":"Le Moigne","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2015.11.013_bib0415","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1378\/chest.09-0132","article-title":"Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005","volume":"136","author":"Razvi","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2015.11.013_bib0420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcf.2004.10.003","article-title":"Immunisation in the current management of cystic fibrosis patients","volume":"4","author":"Malfroot","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.medmal.2015.11.013_bib0425","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1542\/peds.108.4.e62","article-title":"Preimmunization anti-pneumococcal antibody levels are protective in a majority of patients with cystic fibrosis","volume":"108","author":"Lahiri","year":"2001","journal-title":"Pediatrics"},{"issue":"Pt. 12","key":"10.1016\/j.medmal.2015.11.013_bib0430","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1099\/jmm.0.072199-0","article-title":"Characterization of Streptococcus\u00a0pneumoniae clones from paediatric patients with cystic fibrosis","volume":"63","author":"Pimentel de Araujo","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0435","first-page":"CD008865","article-title":"Pneumococcal vaccines for cystic fibrosis","volume":"8","author":"Burgess","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.medmal.2015.11.013_bib0440","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jcf.2014.02.002","article-title":"Pneumococcal polysaccharide vaccine responses are impaired in a subgroup of children with cystic fibrosis","volume":"13","author":"Browning","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.medmal.2015.11.013_bib0445","first-page":"CD001753","article-title":"Vaccines for preventing influenza in people with cystic fibrosis","author":"Dharmaraj","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.medmal.2015.11.013_bib0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2051013613480770","article-title":"Influenza vaccination in children at high risk of respiratory disease","volume":"1","author":"Patria","year":"2013","journal-title":"Ther Adv Vaccines"},{"issue":"35","key":"10.1016\/j.medmal.2015.11.013_bib0455","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1016\/j.vaccine.2014.06.010","article-title":"Factors associated with humoral immune response to pandemic A\/H1N1(v) 2009 influenza vaccine in cystic fibrosis","volume":"32","author":"Launay","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.medmal.2015.11.013_bib0460","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpeds.2008.08.001","article-title":"Impact of pseudomonas and staphylococcal infection on inflammation and clinical status in young children with cystic fibrosis","volume":"154","author":"Sagel","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.medmal.2015.11.013_bib0465","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.201011-1892OC","article-title":"Infection, inflammation, and lung function decline in infants with cystic fibrosis","volume":"184","author":"Pillarisetti","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2015.11.013_bib0470","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/hv.34296","article-title":"Vaccination against respiratory Pseudomonas\u00a0aeruginosa infection","volume":"11","author":"Grimwood","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.medmal.2015.11.013_bib0475","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/fmb.14.42","article-title":"New perspectives in the management of Pseudomonas\u00a0aeruginosa infections","volume":"9","author":"Savoia","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0480","first-page":"CD001399","article-title":"Vaccines for preventing infection with Pseudomonas\u00a0aeruginosa in cystic fibrosis","volume":"6","author":"Johansen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medmal.2015.11.013_bib0485","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4161\/hv.7.10.16369","article-title":"Recent developments for Pseudomonas vaccines","volume":"7","author":"Sharma","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.medmal.2015.11.013_bib0490","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/14760584.4.5.645","article-title":"Application of vaccine technology to prevention of Pseudomonas\u00a0aeruginosa infections","volume":"4","author":"Pier","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.medmal.2015.11.013_bib0495","first-page":"983","article-title":"Parenteral application of a Pseudomonas\u00a0aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals","volume":"151","author":"D\u00f6ring","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2015.11.013_bib0500","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1073\/pnas.0702403104","article-title":"Flagella vaccine trial study, a double-blind randomized placebo-controlled phase III study of a Pseudomonas\u00a0aeruginosa flagella vaccine in cystic fibrosis patients","volume":"104","author":"D\u00f6ring","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.medmal.2015.11.013_bib0505","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.vaccine.2009.10.080","article-title":"Systemic, nasal and oral live vaccines against Pseudomonas\u00a0aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers","volume":"28","author":"Bumann","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2015.11.013_bib0510","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/IAI.00054-09","article-title":"A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas\u00a0aeruginosa","volume":"77","author":"Weimer","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.medmal.2015.11.013_bib0515","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.vaccine.2009.03.010","article-title":"Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas\u00a0aeruginosa in chronic lung disease","volume":"27","author":"Sorichter","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2015.11.013_bib0520","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/apm.12337","article-title":"Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas\u00a0aeruginosa","volume":"123","author":"Farjah","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.medmal.2015.11.013_bib0525","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1574-695X.2006.00103.x","article-title":"Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas\u00a0aeruginosa vaccine in children with cystic fibrosis","volume":"47","author":"Zuercher","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0530","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2249.2005.02964.x","article-title":"Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas\u00a0aeruginosa vaccine","volume":"143","author":"Zuercher","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0535","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/IAI.00157-11","article-title":"Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas\u00a0aeruginosa lung infection in mice","volume":"79","author":"Campod\u00f3nico","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.medmal.2015.11.013_bib0540","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.vaccine.2013.08.078","article-title":"Bovine serum albumin nanoparticle vaccine reduces lung pathology induced by live Pseudomonas\u00a0aeruginosa infection in mice","volume":"31","author":"Rodrigues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2015.11.013_bib0545","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2174\/0929867322666150408111304","article-title":"Exploiting molecular virulence determinants in Burkholderia to develop vaccine antigens","volume":"22","author":"Casey","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.medmal.2015.11.013_bib0550","doi-asserted-by":"crossref","first-page":"e80796","DOI":"10.1371\/journal.pone.0080796","article-title":"Immunoproteomic analysis of proteins expressed by two related pathogens, Burkholderia\u00a0multivorans and Burkholderia\u00a0cenocepacia, during human infection","volume":"8","author":"Shinoy","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.medmal.2015.11.013_bib0555","first-page":"5","article-title":"Burkholderia vaccines: are we moving forward?","volume":"5","author":"Choh","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0560","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.4049\/jimmunol.1402273","article-title":"CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis","volume":"193","author":"Musson","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0565","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00430-009-0137-2","article-title":"Induction of immune response to the 17kDa OMPA Burkholderia\u00a0cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine","volume":"199","author":"Makidon","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0570","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/IAI.01668-06","article-title":"Nasal immunization with Burkholderia\u00a0multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B.\u00a0multivorans and B.\u00a0cenocepacia","volume":"75","author":"Bertot","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.medmal.2015.11.013_bib0575","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF01644186","article-title":"Clinical significance of Staphylococcus\u00a0aureus in cystic fibrosis","volume":"18","author":"Marks","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2015.11.013_bib0580","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/CMR.00068-09","article-title":"The changing microbial epidemiology in cystic fibrosis","volume":"23","author":"LiPuma","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.medmal.2015.11.013_bib0585","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4161\/hv.6.10.12469","article-title":"A new view on development of a Staphylococcus\u00a0aureus vaccine: insights from mice and men","volume":"6","author":"Spellberg","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.medmal.2015.11.013_bib0590","series-title":"Nabi Biopharmaceuticals announces results of StaphVAX(R) Confirmatory Phase III Clinical Trial. Finance.yahoo.com","author":"Release","year":"2005"},{"key":"10.1016\/j.medmal.2015.11.013_bib0595","series-title":"Inhibitex reports top-line results in phase III study of Veronate (R)","year":"2006"},{"key":"10.1016\/j.medmal.2015.11.013_bib0600","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1651-2227.1981.tb05757.x","article-title":"Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma\u2014possible synergism with Pseudomonas\u00a0aeruginosa","volume":"70","author":"Peterson","year":"1981","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.medmal.2015.11.013_bib0605","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0264-410X(03)00098-7","article-title":"Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2015.11.013_bib0610","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/JCM.01313-10","article-title":"Mediastinal tuberculosis in an adult patient with cystic fibrosis","volume":"49","author":"Morand","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0615","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1080\/08035250600724515","article-title":"Cystic fibrosis complicated by multiresistant tuberculosis","volume":"95","author":"Asherova","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.medmal.2015.11.013_bib0620","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1462-5822.2011.01609.x","article-title":"Optimizing vaccine development","volume":"13","author":"Hoft","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.medmal.2015.11.013_bib0625","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/IAI.02032-14","article-title":"Mycobacterium\u00a0abscessus phospholipase C expression is induced during coculture within amoebae and enhances M.\u00a0abscessus virulence in mice","volume":"83","author":"Bakala N\u2019Goma","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.medmal.2015.11.013_bib0630","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1002\/j.1460-2075.1995.tb00119.x","article-title":"A mouse model for the cystic fibrosis delta F508 mutation","volume":"14","author":"van Doorninck","year":"1995","journal-title":"EMBO J"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X15003017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X15003017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:14:35Z","timestamp":1759972475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X15003017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0399077X15003017"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2015.11.013","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine strategies against bacterial pathogens in cystic fibrosis patients","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2015.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}